Detaillierte Beitrags-Information

Zurück zur Liste

Beitragstitel Lebrikizumab Monotherapy Maintained Improvement of Itch and Sleep-Loss Due to Itch After Two Years in Patients with Moderate-to-Severe Atopic Dermatitis
Autoren
  1. Gil Yosipovitch Itch Center, Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Hospital
  2. Peter A. Lio Northwestern University Feinberg School of Medicine; Medical Dermatology Associates of Chicago
  3. David Rosmarin Indiana University School of Medicine
  4. Marta Casillas Eli Lilly and Company
  5. Evangeline Pierce Eli Lilly and Company
  6. Laia Bardolet Almirall
  7. Franz J. Legat Department of Dermatology, Medical University of Graz
  8. Jose-Manuel Carrascosa Dermatology Department, Hospital Universitari Germans Trias i Pujol, UAB, IGTP
  9. Sonja Stander Department of Dermatology and Center for Chronic Pruritus (KCP), University Hospital Münster, Münster Vortragender
Präsentationsform Poster
Themengebiete
  • 1.1 Inflammatory and immune-mediated dermatoses